These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15730346)

  • 1. Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence.
    Ciraulo DA; Sarid-Segal O; Knapp CM; Ciraulo AM; LoCastro J; Bloch DA; Montgomery MA; Leiderman DB; Elkashef A
    Addiction; 2005 Mar; 100 Suppl 1():12-22. PubMed ID: 15730346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine dependence.
    Reid MS; Casadonte P; Baker S; Sanfilipo M; Braunstein D; Hitzemann R; Montgomery A; Majewska D; Robinson J; Rotrosen J
    Addiction; 2005 Mar; 100 Suppl 1():43-57. PubMed ID: 15730349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does combined treatment with novel antidepressants and a dopamine D3 receptor agonist reproduce cocaine discrimination in rats?
    Filip M; Papla I
    Pol J Pharmacol; 2001; 53(6):577-85. PubMed ID: 11985331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.
    Richard IH; McDermott MP; Kurlan R; Lyness JM; Como PG; Pearson N; Factor SA; Juncos J; Serrano Ramos C; Brodsky M; Manning C; Marsh L; Shulman L; Fernandez HH; Black KJ; Panisset M; Christine CW; Jiang W; Singer C; Horn S; Pfeiffer R; Rottenberg D; Slevin J; Elmer L; Press D; Hyson HC; McDonald W;
    Neurology; 2012 Apr; 78(16):1229-36. PubMed ID: 22496199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venlafaxine extended-release: a review of its use in the management of major depression.
    Wellington K; Perry CM
    CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nefazodone treatment of cocaine dependence with comorbid depressive symptoms.
    Ciraulo DA; Knapp C; Rotrosen J; Sarid-Segal O; Ciraulo AM; LoCastro J; Greenblatt DJ; Leiderman D
    Addiction; 2005 Mar; 100 Suppl 1():23-31. PubMed ID: 15730347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placebo-controlled screening trial of celecoxib for the treatment of cocaine dependence.
    Reid MS; Angrist B; Baker S; Woo C; Schwartz M; Montgomery A; Majewska D; Robinson J; Rotrosen J
    Addiction; 2005 Mar; 100 Suppl 1():32-42. PubMed ID: 15730348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder.
    Pollack M; Mangano R; Entsuah R; Tzanis E; Simon NM; Zhang Y
    Psychopharmacology (Berl); 2007 Oct; 194(2):233-42. PubMed ID: 17589833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial.
    Meininger V; Asselain B; Guillet P; Leigh PN; Ludolph A; Lacomblez L; Robberecht W;
    Neurology; 2006 Jan; 66(1):88-92. PubMed ID: 16401852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment.
    Streeter CC; Hennen J; Ke Y; Jensen JE; Sarid-Segal O; Nassar LE; Knapp C; Meyer AA; Kwak T; Renshaw PF; Ciraulo DA
    Psychopharmacology (Berl); 2005 Nov; 182(4):516-26. PubMed ID: 16075286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
    Liebowitz MR; Gelenberg AJ; Munjack D
    Arch Gen Psychiatry; 2005 Feb; 62(2):190-8. PubMed ID: 15699296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments.
    Winhusen TM; Somoza EC; Harrer JM; Mezinskis JP; Montgomery MA; Goldsmith RJ; Coleman FS; Bloch DA; Leiderman DB; Singal BM; Berger P; Elkashef A
    Addiction; 2005 Mar; 100 Suppl 1():68-77. PubMed ID: 15730351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Gee MD; Krishen A; Wunderlich HP; Le Clus A; Evoniuk G; Modell JG
    J Psychopharmacol; 2010 Aug; 24(8):1209-16. PubMed ID: 19939870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled trial of venlafaxine for the treatment of depressed cocaine-dependent patients.
    Raby WN; Rubin EA; Garawi F; Cheng W; Mason E; Sanfilippo L; Lord S; Bisaga A; Aharonovich E; Levin F; McDowell D; Nunes EV
    Am J Addict; 2014; 23(1):68-75. PubMed ID: 24313244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of pramipexole in early Parkinson disease. A randomized dose-ranging study. Parkinson Study Group.
    JAMA; 1997 Jul; 278(2):125-30. PubMed ID: 9214527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.
    Wohlreich MM; Martinez JM; Mallinckrodt CH; Prakash A; Watkin JG; Fava M
    J Clin Psychopharmacol; 2005 Dec; 25(6):552-60. PubMed ID: 16282837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
    Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
    Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
    Holman AJ; Myers RR
    Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.